首页 > 最新文献

Journal of Nuclear Cardiology最新文献

英文 中文
Assessment of liver transplant candidates: What tests De-liver? 肝移植候选者的评估:什么检查去肝?
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102479
Robert C. Hendel MD, MASNC, MACC, FSCCT , Jason D. Stencel MD
{"title":"Assessment of liver transplant candidates: What tests De-liver?","authors":"Robert C. Hendel MD, MASNC, MACC, FSCCT , Jason D. Stencel MD","doi":"10.1016/j.nuclcard.2025.102479","DOIUrl":"10.1016/j.nuclcard.2025.102479","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102479"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145334904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preclinical and first-in-human studies of a novel tracer for single-photon emission computed tomography myocardial blood flow quantification 一种用于SPECT心肌血流定量的新型示踪剂的临床前和首次人体研究。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102441
Yufan Gu MD , Ruoxi Sun MD , Wanjie Ren PhD , Xiaoying Xi MD , Kai Han MS , Zongyao Zhang MS , Shuang Liu PhD , Wei Fang MD , Lei Wang MD

Background

This study aimed to develop a dedicated tracer with high first-pass extraction fraction and stable heart retention for single-photon emission computed tomography (SPECT) myocardial perfusion imaging and flow measurement.

Methods

Three 99mTc-labeled compounds (99mTc-4BOH, 99mTc-3BOH, and 99mTc-2BOH) were evaluated by mouse ex vivo distribution and swine planar imaging studies. 99mTc-4BOH was identified as a candidate and compared with 99mTc-Teboroxime and 99mTc-Sestamibi in swine on cadmium zinc telluride SPECT to study organ uptake and kinetic properties. Head-to-head comparisons of 99mTc-4BOH with 99mTc-Sestamibi and 13N–NH3 were performed on two separate pilot cohorts each comprising 10 patients.

Results

The myocardial uptake of 99mTc-4BOH demonstrated significantly higher levels than 99mTc-Sestamibi in swine and human, evidenced by higher K1 values (swine rest: .81 ± .03 mL/g/min vs .43 ± .09 mL/g/min, P < .001; stress: 1.19 ± .26 mL/g/min vs .50 ± .10 mL/g/min, P < .001; human rest: .74 ± .09 mL/g/min vs .38 ± .04 mL/g/min, P < .001; stress 1.42 ± .17 mL/g/min vs .59 ± .07 mL/g/min, P < .001). k2 values of 99mTc-4BOH were lower than those of 99mTc-Teboroxime (rest: .18 ± .03/min vs .26 ± .01/min, P < .001; stress: .26 ± .04/min vs .38 ± .08/min, P < .01), suggesting greater stability than 99mTc-Teboroxime in the swine. Three- to 8-min data after injection are sufficient to produce high-quality perfusion images that offer clear visualization of the myocardium and minimal interference artifacts due to favorable heart-to-liver ratios of 99mTc-4BOH. Furthermore, K1 values from 99mTc-4BOH SPECT significantly correlated with 13N–NH3 positron emission tomography myocardial blood flow (MBF) (ρ = .83 on per-patient level, P < .001; ρ = .81 on per-vessel level, P < .001).

Conclusions

99mTc-4BOH exhibited an encouraging pharmacokinetic profile with high and relatively stable cardiac uptake. It constitutes a promising candidate as myocardial perfusion radiotracer for SPECT MBF quantification.
背景:本研究旨在开发一种具有高第一次提取分数和稳定心脏保留的专用示踪剂,用于SPECT心肌灌注成像和血流测量。方法:通过小鼠离体分布和猪平面成像研究,对3种99mtc标记化合物(99mTc-4BOH、99mTc-3BOH和99mTc-2BOH)进行评价。将99mTc-4BOH确定为候选药物,并在镉锌碲化SPECT上与99mtc - teboroxme和99mTc-Sestamibi进行比较,研究其在猪体内的器官摄取和动力学特性。99mTc-4BOH与99mTc-Sestamibi和13N-NH3在两个独立的试点队列中进行了正面比较,每个队列包括10名患者。结果:99mTc-4BOH在猪和人的心肌摄取水平显著高于99mTc-Sestamibi,表现为K1值较高(猪休息:0.81±0.03 mL/g/min vs. 0.43±0.09 mL/g/min), P2值低于99mtc - teboroxme(猪休息:0.18±0.03 mL/ min vs. 0.26±0.01 /min), p99mtc - teboroxme在猪的心肌摄取水平。注射后3-8分钟的数据足以产生高质量的灌注图像,心肌清晰可见,由于99mTc-4BOH的有利心/肝比,干扰最小。此外,99mTc-4BOH SPECT的K1值与13N-NH3 PET MBF显著相关(在每个患者水平上ρ=0.83)。结论:99mTc-4BOH表现出令人鼓舞的药代动力学特征,具有高且相对稳定的心脏摄取。它是一种很有前途的候选心肌灌注放射性示踪剂,用于SPECT MBF定量。
{"title":"Preclinical and first-in-human studies of a novel tracer for single-photon emission computed tomography myocardial blood flow quantification","authors":"Yufan Gu MD ,&nbsp;Ruoxi Sun MD ,&nbsp;Wanjie Ren PhD ,&nbsp;Xiaoying Xi MD ,&nbsp;Kai Han MS ,&nbsp;Zongyao Zhang MS ,&nbsp;Shuang Liu PhD ,&nbsp;Wei Fang MD ,&nbsp;Lei Wang MD","doi":"10.1016/j.nuclcard.2025.102441","DOIUrl":"10.1016/j.nuclcard.2025.102441","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to develop a dedicated tracer with high first-pass extraction fraction and stable heart retention for single-photon emission computed tomography (SPECT) myocardial perfusion imaging and flow measurement.</div></div><div><h3>Methods</h3><div>Three <sup>99m</sup>Tc-labeled compounds (<sup>99m</sup>Tc-4BOH, <sup>99m</sup>Tc-3BOH, and <sup>99m</sup>Tc-2BOH) were evaluated by mouse ex vivo distribution and swine planar imaging studies. <sup>99m</sup>Tc-4BOH was identified as a candidate and compared with <sup>99m</sup>Tc-Teboroxime and <sup>99m</sup>Tc-Sestamibi in swine on cadmium zinc telluride SPECT to study organ uptake and kinetic properties. Head-to-head comparisons of <sup>99m</sup>Tc-4BOH with <sup>99m</sup>Tc-Sestamibi and <sup>13</sup>N–NH<sub>3</sub> were performed on two separate pilot cohorts each comprising 10 patients.</div></div><div><h3>Results</h3><div>The myocardial uptake of <sup>99m</sup>Tc-4BOH demonstrated significantly higher levels than <sup>99m</sup>Tc-Sestamibi in swine and human, evidenced by higher <em>K</em><sub><em>1</em></sub> values (swine rest: .81 ± .03 mL/g/min vs .43 ± .09 mL/g/min, <em>P</em> &lt; .001; stress: 1.19 ± .26 mL/g/min vs .50 ± .10 mL/g/min, <em>P</em> &lt; .001; human rest: .74 ± .09 mL/g/min vs .38 ± .04 mL/g/min, <em>P</em> &lt; .001; stress 1.42 ± .17 mL/g/min vs .59 ± .07 mL/g/min, <em>P</em> &lt; .001). <em>k</em><sub><em>2</em></sub> values of <sup>99m</sup>Tc-4BOH were lower than those of <sup>99m</sup>Tc-Teboroxime (rest: .18 ± .03/min vs .26 ± .01/min, <em>P</em> &lt; .001; stress: .26 ± .04/min vs .38 ± .08/min, <em>P</em> &lt; .01), suggesting greater stability than <sup>99m</sup>Tc-Teboroxime in the swine. Three- to 8-min data after injection are sufficient to produce high-quality perfusion images that offer clear visualization of the myocardium and minimal interference artifacts due to favorable heart-to-liver ratios of <sup>99m</sup>Tc-4BOH. Furthermore, <em>K</em><sub><em>1</em></sub> values from <sup>99m</sup>Tc-4BOH SPECT significantly correlated with <sup>13</sup>N–NH<sub>3</sub> positron emission tomography myocardial blood flow (MBF) (ρ = .83 on per-patient level, <em>P</em> &lt; .001; ρ = .81 on per-vessel level, <em>P</em> &lt; .001).</div></div><div><h3>Conclusions</h3><div><sup>99m</sup>Tc-4BOH exhibited an encouraging pharmacokinetic profile with high and relatively stable cardiac uptake. It constitutes a promising candidate as myocardial perfusion radiotracer for SPECT MBF quantification.</div></div>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102441"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The power of participation: ASNC’s strength is YOU 参与的力量:ASNC的力量在于您
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102499
Panithaya Chareonthaitawee MD, MASNC
{"title":"The power of participation: ASNC’s strength is YOU","authors":"Panithaya Chareonthaitawee MD, MASNC","doi":"10.1016/j.nuclcard.2025.102499","DOIUrl":"10.1016/j.nuclcard.2025.102499","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102499"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145334902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of rubidium-82 positron emission tomography in a multimodality approach to diagnosing coronary microvascular dysfunction in apical hypertrophic cardiomyopathy 铷-82正电子发射断层扫描在多模态诊断冠状动脉微血管功能障碍的作用。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102197
Kutaiba Nazif DO , A. Sami Abuzaid MD , Stephen Horgan MB, BCh, PhD , Krishna K. Patel MD, MSc , Matthieu Pelletier-Galarneau MD, MBA, FASNC , Tamara Naneishvili MD , Gary Heller MD, PhD , Parthiban Arumugam MD, FASNC
{"title":"Role of rubidium-82 positron emission tomography in a multimodality approach to diagnosing coronary microvascular dysfunction in apical hypertrophic cardiomyopathy","authors":"Kutaiba Nazif DO ,&nbsp;A. Sami Abuzaid MD ,&nbsp;Stephen Horgan MB, BCh, PhD ,&nbsp;Krishna K. Patel MD, MSc ,&nbsp;Matthieu Pelletier-Galarneau MD, MBA, FASNC ,&nbsp;Tamara Naneishvili MD ,&nbsp;Gary Heller MD, PhD ,&nbsp;Parthiban Arumugam MD, FASNC","doi":"10.1016/j.nuclcard.2025.102197","DOIUrl":"10.1016/j.nuclcard.2025.102197","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102197"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143730480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of PET-CT and CZT-SPECT on myocardial blood flow and flow reserve measurement: A systematic review and meta-analysis PET-CT与CZT-SPECT对心肌血流量和血流储备测量的比较:系统综述和荟萃分析。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102279
Davi Shunji Yahiro , Luís Felipe Leite , Giovane L. Azevedo , Mouaz H. Al-Mallah MD, MSc, MASNC , Claudio Tinoco Mesquita MD, PhD, FASNC

Background

Myocardial blood flow (MBF) and myocardial flow reserve (MFR) measurement is crucial for diagnosing and managing coronary artery disease and microvascular dysfunction. While positron emission tomography (PET) is the gold standard, cadmium zinc telluride (CZT) is more accessible. This systematic review and meta-analysis aim to compare the accuracy, and the systematic bias of MBF and MFR measurement using CZT compared with PET.

Methods

We conducted a systematic review across multiple databases up to April 2024. The main outcomes were mean difference between MBF and MFR values obtained from PET and CZT, limits of agreement, and diagnostic performance. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool and statistical analysis was conducted using random effects models.

Results

Eight studies, encompassing 268 patients, met the inclusion criteria. The mean difference for rest and stress myocardial blood flow between PET and CZT was .006 (95% confidence interval [CI]: −.088, .100) and .111 (95% CI: −.418, .195), respectively. The myocardial flow reserve mean difference was .0178 (95% CI: −.492, .135). Bland–Altman meta-analysis demonstrated a bias of .05 mL/min/g (95%CI: −1.08 to 1.24) for rest MBF, .13 mL/min/g for stress MBF (95%CI: −.969 to 1.228), and .03 mL/min/g (95%CI: −.999, 1.006) bias for MFR. The diagnostic performance for detecting significant reductions in MBF and MFR on single-photon emission computed tomography using PET as the gold standard demonstrated sensitivity and specificity of 80.8% and 87.0%, respectively.

Conclusions

CZT MBF measurements demonstrated good agreement with PET, although they had a slight underestimation. While PET remains the preferred modality due to its superior performance, CZT represents a viable alternative when PET is unavailable. Future research should focus on standardizing CZT protocols.
背景:心肌血流(MBF)和心肌血流储备(MFR)测量是诊断和治疗冠状动脉疾病和微血管功能障碍的关键。虽然正电子发射断层扫描(PET)是金标准,但碲化镉锌(CZT)更容易获得。本系统综述和荟萃分析旨在比较使用CZT与PET测量MBF和MFR的准确性和系统偏差。方法:我们对截至2024年4月的多个数据库进行了系统评价。主要结果为PET和CZT测得的MBF和MFR值的平均差异、一致性限和诊断表现。使用QUADAS-2工具评估偏倚风险,并使用随机效应模型进行统计分析。结果:8项研究,包括268例患者,符合纳入标准。PET和CZT的静息心肌血流量和应激心肌血流量的平均差异分别为0.006 (95% CI: -0.088, 0.100)和0.111 (95% CI: -0.418, 0.195)。心肌血流储备平均差异为0.0178 (95% CI: -0.492, 0.135)。Bland-Altman荟萃分析显示,休息MBF的偏倚为0.05 mL/min/g (95%CI: -1.08至1.24),应激MBF的偏倚为0.13 mL/min/g (95%CI: -0.969至1.228),MFR的偏倚为0.03 mL/min/g (95%CI: -0.999, 1.006)。使用PET作为金标准,在SPECT上检测MBF和MFR显著降低的诊断性能分别显示出80.8%和87.0%的敏感性和特异性。结论:CZT MBF测量结果与PET测量结果一致,但有轻微的低估。虽然PET由于其优越的性能仍然是首选的方式,但当PET不可用时,CZT代表了一种可行的替代方案。未来的研究重点应放在标准化CZT协议上。
{"title":"Comparison of PET-CT and CZT-SPECT on myocardial blood flow and flow reserve measurement: A systematic review and meta-analysis","authors":"Davi Shunji Yahiro ,&nbsp;Luís Felipe Leite ,&nbsp;Giovane L. Azevedo ,&nbsp;Mouaz H. Al-Mallah MD, MSc, MASNC ,&nbsp;Claudio Tinoco Mesquita MD, PhD, FASNC","doi":"10.1016/j.nuclcard.2025.102279","DOIUrl":"10.1016/j.nuclcard.2025.102279","url":null,"abstract":"<div><h3>Background</h3><div><span>Myocardial blood flow<span><span> (MBF) and myocardial flow<span><span> reserve (MFR) measurement is crucial for diagnosing and managing coronary artery disease and microvascular dysfunction. While </span>positron emission </span></span>tomography (PET) is the gold standard, </span></span>cadmium zinc telluride<span> (CZT) is more accessible. This systematic review and meta-analysis aim to compare the accuracy, and the systematic bias of MBF and MFR measurement using CZT compared with PET.</span></div></div><div><h3>Methods</h3><div>We conducted a systematic review<span> across multiple databases up to April 2024. The main outcomes were mean difference between MBF and MFR values obtained from PET and CZT, limits of agreement, and diagnostic performance. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 tool and statistical analysis was conducted using random effects models.</span></div></div><div><h3>Results</h3><div><span><span>Eight studies, encompassing 268 patients, met the inclusion criteria. The mean difference for rest and stress myocardial blood flow between PET and CZT was .006 (95% confidence interval [CI]: −.088, .100) and .111 (95% CI: −.418, .195), respectively. The </span>myocardial flow reserve mean difference was .0178 (95% CI: −.492, .135). Bland–Altman meta-analysis demonstrated a bias of .05 mL/min/g (95%CI: −1.08 to 1.24) for rest MBF, .13 mL/min/g for stress MBF (95%CI: −.969 to 1.228), and .03 mL/min/g (95%CI: −.999, 1.006) bias for MFR. The diagnostic performance for detecting significant reductions in MBF and MFR on single-photon emission computed </span>tomography using PET as the gold standard demonstrated sensitivity and specificity of 80.8% and 87.0%, respectively.</div></div><div><h3>Conclusions</h3><div>CZT MBF measurements demonstrated good agreement with PET, although they had a slight underestimation. While PET remains the preferred modality due to its superior performance, CZT represents a viable alternative when PET is unavailable. Future research should focus on standardizing CZT protocols.</div></div>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102279"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144317156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved diagnostic performance of 18F-flurpiridaz positron emission tomography myocardial blood flow quantification with automated dynamic motion correction 18F-flurpiridaz PET心肌血流定量自动动态运动校正提高诊断性能。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102450
Jennifer M. Renaud MSc , Jonathan B. Moody PhD , Michael D. Vanderver MSA, CNMT , Alexis Poitrasson-Rivière PhD , Christopher J. Buckley PhD , Edward P. Ficaro PhD , Venkatesh L. Murthy MD, PhD
{"title":"Improved diagnostic performance of 18F-flurpiridaz positron emission tomography myocardial blood flow quantification with automated dynamic motion correction","authors":"Jennifer M. Renaud MSc ,&nbsp;Jonathan B. Moody PhD ,&nbsp;Michael D. Vanderver MSA, CNMT ,&nbsp;Alexis Poitrasson-Rivière PhD ,&nbsp;Christopher J. Buckley PhD ,&nbsp;Edward P. Ficaro PhD ,&nbsp;Venkatesh L. Murthy MD, PhD","doi":"10.1016/j.nuclcard.2025.102450","DOIUrl":"10.1016/j.nuclcard.2025.102450","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102450"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144731792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new single-photon emission computed tomography blood flow tracer? Perhaps, but a long journey ahead 一种新的单光子发射计算机断层血流追踪器?也许吧,但前面还有很长的路要走
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102475
James A. Case PhD, MASNC
{"title":"A new single-photon emission computed tomography blood flow tracer? Perhaps, but a long journey ahead","authors":"James A. Case PhD, MASNC","doi":"10.1016/j.nuclcard.2025.102475","DOIUrl":"10.1016/j.nuclcard.2025.102475","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102475"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145334546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What if SPECT could do it all? 如果SPECT能做到这一切呢?
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102510
Marcelo F. Di Carli MD, MASNC
{"title":"What if SPECT could do it all?","authors":"Marcelo F. Di Carli MD, MASNC","doi":"10.1016/j.nuclcard.2025.102510","DOIUrl":"10.1016/j.nuclcard.2025.102510","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102510"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145334901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Priming with specific context improves large language model performance on nuclear cardiology board preparation test 特定语境启动提高了核心脏科板准备测试中大型语言模型的性能。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102269
Waseem Hijazi MD , Valerie Builoff BS , Aditya Killekar MSc , Aakash Shanbhag MSc , Robert J.H. Miller MD , Damini Dey PhD , Joanna X. Liang MPH , Kathleen Flood BS , Daniel Berman MD , Jamieson M. Bourque MD, MHS , Lawrence M. Phillips MD, MASNC , Panithaya Chareonthaitawee MD , Piotr J. Slomka PhD, MASNC
{"title":"Priming with specific context improves large language model performance on nuclear cardiology board preparation test","authors":"Waseem Hijazi MD ,&nbsp;Valerie Builoff BS ,&nbsp;Aditya Killekar MSc ,&nbsp;Aakash Shanbhag MSc ,&nbsp;Robert J.H. Miller MD ,&nbsp;Damini Dey PhD ,&nbsp;Joanna X. Liang MPH ,&nbsp;Kathleen Flood BS ,&nbsp;Daniel Berman MD ,&nbsp;Jamieson M. Bourque MD, MHS ,&nbsp;Lawrence M. Phillips MD, MASNC ,&nbsp;Panithaya Chareonthaitawee MD ,&nbsp;Piotr J. Slomka PhD, MASNC","doi":"10.1016/j.nuclcard.2025.102269","DOIUrl":"10.1016/j.nuclcard.2025.102269","url":null,"abstract":"","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102269"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144258280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blunted hemodynamic response to pharmacological stress is predictive of mortality in liver transplant candidates 对药物应激的钝化血流动力学反应可预测肝移植候选者的死亡率。
IF 2.7 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-10-01 DOI: 10.1016/j.nuclcard.2025.102454
Ibolya Csecs MD, PhD , Aakanksha Sharma MBBS , Vandana Khungar MD, MSc , Albert J. Sinusas MD , Stephen Possick MD , Edward J. Miller MD, PhD , Attila Feher MD, PhD

Background

The optimal method for evaluating coronary artery disease in liver transplant candidates (LTCs) remains controversial. To date no studies have compared the hemodynamic and symptomatic response to vasodilator stress between LTCs and patients without chronic liver disease.

Methods

We conducted a retrospective study of LTCs who underwent regadenoson nuclear stress testing with either 99mTc-tetrofosmin single-photon emission computed tomography (SPECT; N = 224) or 82Rubidium positron emission tomography (N = 36). These patients were compared to controls matched for age, sex, body mass index, cardiovascular comorbidities, and imaging modality who underwent clinically indicated regadenoson stress test.

Results

LTCs were less likely to experience symptoms in response to regadenoson than controls (65% vs 86 %, P < .001). Additionally, the increase in heart rate was blunted in LTCs (ΔHR: 13 beats per minute [bpm], interquartile range [IQR]: 11-15 vs 29 bpm, IQR: 27-31, P < .001). During the median follow-up period of 2.0 ± 1.5 years, 78 deaths occurred in LTCs. In the multivariable analysis, ΔHR (hazard ratio [HZR]: .975, 95% confidence interval [CI]: .951–.999, P = .042) and changes in diastolic blood pressure (ΔDBP, HZR: 1.037, 95% CI: 1.003-1.071, P = .031) were significantly associated with mortality regardless of Model for End-stage Liver Disease (MELD) score, age, cardiovascular comorbidities, and stress test results. In addition, LTCs with both high MELD score (≥15) and low ΔHR (≤10 bpm) had worse overall survival than patients with a low MELD score (<15) and high ΔHR (>10 bpm, HZR: 5.54, 95% CI: 3.21-9.53, P < .001), low MELD score and low ΔHR (HZR: 6.62, 95% CI: 3.25-13.49, P < .001), and high MELD score and low ΔHR (HZR: 2.91, 95% CI: 1.50-5.64, P = .002).

Conclusions

In this retrospective cohort analysis, LTCs exhibited a reduced hemodynamic response detected as lower ΔHR as well as fewer symptoms in response to regadenoson during stress testing. Reduced hemodynamic response was significantly associated with mortality and provided incremental prognostic value in addition to MELD score. Further prospective studies are required to validate these findings.
背景:评估肝移植候选者(LTCs)冠状动脉病变(CAD)的最佳方法仍存在争议。到目前为止,还没有研究比较LTCs和非慢性肝病患者对血管扩张剂应激的血流动力学和症状反应。方法:我们对使用99mTc-tetrofosmin SPECT (n=224)或82Rubidium PET (n=36)进行核应激测试的LTCs进行了回顾性研究。将这些患者与对照组进行年龄、性别、体重指数、心血管合并症和影像学方式相匹配的对照,并进行临床指示的再腺苷松压力测试。结果:与对照组相比,LTCs对regadenoson的反应不太可能出现症状(65%对86%,p< 0.001)。此外,LTCs的心率增加被减弱(ΔHR, 13次/分钟[bpm],四分位数范围:11-15 vs. 29 bpm,四分位数范围:27-31,p< 0.001)。中位随访期为2.0±1.5年,LTCs患者死亡78例。在多因素分析中,ΔHR(风险比[HR]: 0.975, 95%可信区间[CI]: 0.951-0.999, p=0.042)和舒张压变化(ΔDBP, HR: 1.037, 95% CI: 1.003-1.071, p=0.031)与死亡率显著相关,与终末期肝病模型(MELD)评分、年龄、心血管合并症和压力测试结果无关。此外,高MELD评分(≥15)和低ΔHR(≤10 bpm)的LTC患者与低MELD评分(10 bpm, HR: 5.54, 95% CI: 3.21-9.53, p)的患者相比,总生存期更差。结论:在这项回顾性队列分析中,LTC表现出较低的血流动力学反应,检测到较低的ΔHR,收缩压和舒张压,以及应激测试中对再adenoson的反应症状较少。血流动力学反应的降低与死亡率显著相关,并且除了MELD评分外,还提供了增加的预后价值。需要进一步的前瞻性研究来验证这些发现。
{"title":"Blunted hemodynamic response to pharmacological stress is predictive of mortality in liver transplant candidates","authors":"Ibolya Csecs MD, PhD ,&nbsp;Aakanksha Sharma MBBS ,&nbsp;Vandana Khungar MD, MSc ,&nbsp;Albert J. Sinusas MD ,&nbsp;Stephen Possick MD ,&nbsp;Edward J. Miller MD, PhD ,&nbsp;Attila Feher MD, PhD","doi":"10.1016/j.nuclcard.2025.102454","DOIUrl":"10.1016/j.nuclcard.2025.102454","url":null,"abstract":"<div><h3>Background</h3><div>The optimal method for evaluating coronary artery disease in liver transplant candidates (LTCs) remains controversial. To date no studies have compared the hemodynamic and symptomatic response to vasodilator stress between LTCs and patients without chronic liver disease.</div></div><div><h3>Methods</h3><div>We conducted a retrospective study of LTCs who underwent regadenoson nuclear stress testing with either <sup>99m</sup>Tc-tetrofosmin single-photon emission computed tomography (SPECT; N = 224) or <sup>82</sup>Rubidium positron emission tomography (N = 36). These patients were compared to controls matched for age, sex, body mass index, cardiovascular comorbidities, and imaging modality who underwent clinically indicated regadenoson stress test.</div></div><div><h3>Results</h3><div>LTCs were less likely to experience symptoms in response to regadenoson than controls (65% vs 86 %, <em>P</em> &lt; .001). Additionally, the increase in heart rate was blunted in LTCs (ΔHR: 13 beats per minute [bpm], interquartile range [IQR]: 11-15 vs 29 bpm, IQR: 27-31, <em>P</em> &lt; .001). During the median follow-up period of 2.0 ± 1.5 years, 78 deaths occurred in LTCs. In the multivariable analysis, ΔHR (hazard ratio [HZR]: .975, 95% confidence interval [CI]: .951–.999, <em>P</em> = .042) and changes in diastolic blood pressure (ΔDBP, HZR: 1.037, 95% CI: 1.003-1.071, <em>P</em> = .031) were significantly associated with mortality regardless of Model for End-stage Liver Disease (MELD) score, age, cardiovascular comorbidities, and stress test results. In addition, LTCs with both high MELD score (≥15) and low ΔHR (≤10 bpm) had worse overall survival than patients with a low MELD score (&lt;15) and high ΔHR (&gt;10 bpm, HZR: 5.54, 95% CI: 3.21-9.53, <em>P</em> &lt; .001), low MELD score and low ΔHR (HZR: 6.62, 95% CI: 3.25-13.49, <em>P</em> &lt; .001), and high MELD score and low ΔHR (HZR: 2.91, 95% CI: 1.50-5.64, <em>P</em> = .002).</div></div><div><h3>Conclusions</h3><div>In this retrospective cohort analysis, LTCs exhibited a reduced hemodynamic response detected as lower ΔHR as well as fewer symptoms in response to regadenoson during stress testing. Reduced hemodynamic response was significantly associated with mortality and provided incremental prognostic value in addition to MELD score. Further prospective studies are required to validate these findings.</div></div>","PeriodicalId":16476,"journal":{"name":"Journal of Nuclear Cardiology","volume":"52 ","pages":"Article 102454"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144794739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Nuclear Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1